Market Cap

EUR 115.6B

Volume

1.5M

Cash and Equivalents

N/A

EBITDA

EUR 12.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 33.5B

Profit Margin

69.12%

52 Week High

EUR 106.14

52 Week Low

EUR 84.93

Dividend

4.08%

Price / Book Value

1.59

Price / Earnings

25.68

Price / Tangible Book Value

25.70

Enterprise Value

EUR 132.8B

Enterprise Value / EBITDA

10.43

Operating Income

EUR 9.0B

Return on Equity

N/A

Return on Assets

N/A

Cash and Short Term Investments

EUR 6.8B

Debt

EUR 23.8B

Equity

EUR 73.0B

Revenue

EUR 48.4B

Unlevered FCF

N/A

Sector

Pharmaceuticals

Category

N/A